Patrick Soon‐Shiong

11.5k citations

162 papers · 7.9k indexed · 5 hit papers · h-index 37

Impact in

Biomaterials top 0.5%
- Nanoparticle-Based Drug Delivery
Oncology top 0.5%
- Pancreatic and Hepatic Oncology Research
- Cancer Treatment and Pharmacology
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers

Papers in

Oncology 69
- Cancer Immunotherapy and Biomarkers 35
- CAR-T cell therapy research 25
- Cancer Treatment and Pharmacology 14
Immunology 45
- Immune Cell Function and Interaction 26
- Immunotherapy and Immune Responses 17

Co-authors: Neil Desai Michael Hawkins Vuong Trieu Gudmund Skjåk‐Bræk Terje Espevik Olav Smidsrød Zhiwen Yao Per Bruheim
Journals: Journal of Clinical Oncology (24 papers)Cancer Research (7 papers)Journal for ImmunoTherapy of Cancer (7 papers)Scientific Reports (5 papers)Oncotarget (5 papers)
Partner nations: United States Italy Canada

In The Last Decade

Patrick Soon‐Shiong

150 papers receiving 7.6k citations

Hit Papers

5 papers align trajectories log scale

Gemcitabine Plusnab-Paclitaxel Is an Active Regimen in Patients With Advanced Pancreatic Cancer: A Phase I/II Trial 2011 · 823 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2011 Journal of Clinical Oncology
2008 Advanced Drug Delivery Reviews
2006 Clinical Cancer Research
2002 PubMed
1994 The Lancet

Peers

Countries citing papers authored by Patrick Soon‐Shiong

Since Specialization

Citations

This map shows the geographic impact of Patrick Soon‐Shiong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick Soon‐Shiong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick Soon‐Shiong more than expected).

Fields of papers citing papers by Patrick Soon‐Shiong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrick Soon‐Shiong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick Soon‐Shiong. The network helps show where Patrick Soon‐Shiong may publish in the future.

Co-authors

The 25 scholars most cited alongside Patrick Soon‐Shiong, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Patrick Soon‐Shiong Line = papers co-authored together Patrick Soon‐Shiong links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	The quadruple immunotherapy for colorectal cancer (QuICC) trial for mismatch repair-proficient metastatic colorectal cancer The Oncologist ·Dara Bracken‐Clarke, Danielle M. Pastor, Jennifer L. Marté, Renee N. Donahue, James W. Hodge, Lisa M. Cordes, Charalampos S. Floudas, Nicholas Tschernia, Fatima Karzai, 陈亚杰, 付正中, Patrick Soon‐Shiong, Leopoldo Tullio, Ling Shaozhi, Hoyoung Maeng, Julius Strauss, Jason M. Redman	2026	0
2	Case report: PD-L1-targeted high-affinity natural killer cells and IL-15 superagonist N-803-based therapy extend overall survival of advanced metastatic pancreatic cancer patients Frontiers in Oncology ·Tara Elisabeth Seery, Bermúdez Pérez,, Susana, J. W. GOUGH, Frank R. Jones, Patricia Spilman, Sandeep Reddy, Patrick Soon‐Shiong	2025	3
3	Transient overexpression of hPKM2 in porcine cardiomyocytes prevents heart failure after myocardial infarction Nature Communications ·Jiacheng Sun, Yalin Wu, D Molina, W. J. Rood, Ann Kurian, Magdalena M. Żak, Alifah Yulianingsih, L. V.S. [UNESP] Sacramento, Harry T. Lawless, Yu Lu, Patrick Soon‐Shiong, Gregory P. Walcott, Hesham A. Sadek, Jianyi Zhang, Lior Zangi	2025	0
4	Characterization of lysate from NK-92 cells and its potential use as an immunotherapeutic modality Cellular Immunology ·L Avedikian, Laurent Boissel, Courtney J. Fleenor, Thomas E. Bickett, Zhimin Guo, Luca Pappalardo, Manju Saxena, Patrick Soon‐Shiong, Hans Klingemann	2025	1
5	CTIM-23. FIRST-IN-HUMAN IMMUNOTHERAPY TARGETING LYMPHOPENIA IN RECURRENT GLIOBLASTOMA MULTIFORM (GBM): NAI AND PD-L1 T-HANK PLUS BEVACIZUMAB WITH COMPLETE RESPONSE Neuro-Oncology ·Simon Khagi, Jose Carrillo, David Park, Leylah Drusbosky, Paul Bhar, Hui Zhang, Bermúdez Pérez,, Susana, Sandeep K. Reddy, Santosh Kesari, Patrick Soon‐Shiong	2025	0
6	MP16-03 N-803 PLUS BCG COMPLETE RESPONSE RATE IN NMIBC CIS SUBJECTS: BCG REFRACTORY, RELAPSED, CHECKPOINT FAILURE, AND CHEMOTHERAPY FAILURE; UPDATED RESULTS (QUILT 3.032) The Journal of Urology ·Patrick Soon‐Shiong, Sandeep K. Reddy, Karim Chamie	2024	2
7	Assessment of the impact of a personalised nutrition intervention in impaired glucose regulation over 26 weeks: a randomised controlled trial Scientific Reports ·Maria Karvela, Penn Siri Gladys, Likhawan Layinatuzzain, Iso Camartin, Nina Noeske, Abhishek Oswal, Pierre De Beaudrap, Sara de Mateo, GRETCHEN WRIGHT, Yun Qin, M. Liang, Ruben Ladeira, Javier Simón‐Sánchez, Rashmita Sahoo, Jonathan Pearson‐Stuttard, Patrick Soon‐Shiong, C. Toumazou, Nick Oliver	2024	10
8	1631P Results from the quick efficacy seeking trial (QuEST1) arm combining BN-brachyury (BNVax) + bintrafusp alfa (BA) + nogapendekin alfa inbakicept-pmln (N-803) in castration-resistant prostate cancer (CRPC) Annals of Oncology ·Jason M. Redman, Ravi A. Madan, Fatima Karzai, Lisa M. Cordes, Chair Polly E. Parsons, N. Williams, Amy Hankin, Nicole Toney, Renee N. Donahue, Seth M. Steinberg, Patrick Soon‐Shiong, Jeffrey Schlom, Evrim Türkbey, James L. Gulley	2024	1
9	Intranasal plus subcutaneous prime vaccination with a dual antigen COVID-19 vaccine elicits T-cell and antibody responses in mice Scientific Reports ·Adrian Rice, Mohit S. Verma, Benjamin Geva, Yuanchun Yu, Peter A. Sieling, Shiho Tanaka, Joseph P. Balint, 彰吾古川, Helty Adisetiyo, Gabrielle Aquino Ferreira Nery, Wendy Higashide, C. Anders Olson, Н. В. Олійник, Patricia Spilman, Ankit Bhattacharyya, Jeffrey T. Safrit, Shahrooz Rabizadeh, Kayvan Niazi, Patrick Soon‐Shiong	2021	26
10	Combinatorial Natural Killer Cell–based Immunotherapy Approaches Selectively Target Chordoma Cancer Stem Cells Cancer Research Communications ·Austin T.K. Hoke, Michelle R. Padget, Kellsye P. Fabian, Anjali Nandal, Gary L. Gallia, Marijo Bilušić, Patrick Soon‐Shiong, James W. Hodge, Nyall R. London	2021	14
11	Combinatorial immunotherapy of N-803 (IL-15 superagonist) and dinutuximab with ex vivo expanded natural killer cells significantly enhances in vitro cytotoxicity against GD2⁺ pediatric solid tumors and in vivo survival of xenografted immunodeficient NSG mice Journal for ImmunoTherapy of Cancer ·Yaya Chu, Gaurav Nayyar, Jin Kenzaki, Jeremy Rosenblum, Patrick Soon‐Shiong, Jeffrey T. Safrit, Dean A. Lee, Mitchell S. Cairo	2021	31
12	Phase I study of a multitargeted recombinant Ad5 PSA/MUC-1/brachyury-based immunotherapy vaccine in patients with metastatic castration-resistant prostate cancer (mCRPC) Journal for ImmunoTherapy of Cancer ·Marijo Bilušić, Sheri McMahon, Ravi A. Madan, Fatima Karzai, J. Briffaud, Renee N. Donahue, Claudia Palena, Caroline Jochéms, Jennifer L. Marté, Charalampos S. Floudas, Julius Strauss, Jason M. Redman, Houssein Abdul Sater, Shahrooz Rabizadeh, Patrick Soon‐Shiong, Jeffrey Schlom, James L. Gulley	2021	43
13	Novel cytokine–antibody fusion protein, N-820, to enhance the functions of ex vivo expanded natural killer cells against Burkitt lymphoma Journal for ImmunoTherapy of Cancer ·Yaya Chu, Gaurav Nayyar, Nang Kham Su, Jeremy Rosenblum, Patrick Soon‐Shiong, J. Jack Lee, Jeffrey T. Safrit, Matthew J. Barth, Dean A. Lee, Mitchell S. Cairo	2020	11
14	Cooperative Immune-Mediated Mechanisms of the HDAC Inhibitor Entinostat, an IL15 Superagonist, and a Cancer Vaccine Effectively Synergize as a Novel Cancer Therapy Clinical Cancer Research ·Kristin C. Hicks, Karin M. Knudson, Karin L. Lee, Duane H. Hamilton, James W. Hodge, William D. Figg, Peter Ordentlich, Frank R. Jones, Shahrooz Rabizadeh, Patrick Soon‐Shiong, Jeffrey Schlom, Sofia R. Gameiro	2019	37
15	Efficient Tumor Clearance and Diversified Immunity through Neoepitope Vaccines and Combinatorial Immunotherapy Cancer Immunology Research ·Karin L. Lee, Stephen C. Benz, Kristin C. Hicks, Andrew Nguyen, Sofia R. Gameiro, Claudia Palena, Hao Cai, Zhen Su, Peter Ordentlich, Lars Rohlin, 叶松, Shahrooz Rabizadeh, Patrick Soon‐Shiong, Kayvan Niazi, Jeffrey Schlom, Duane H. Hamilton	2019	20
16	Learning subgroup-specific regulatory interactions and regulator independence with PARADIGM Bioinformatics ·Andrew J. Sedgewick, Stephen C. Benz, Shahrooz Rabizadeh, Patrick Soon‐Shiong, Charles Vaske	2013	19
17	Proceedings of the 2nd Conference on Wireless Health I. M. Jacobs, Patrick Soon‐Shiong, Eric J. Topol, C. Toumazou	2011	5
18	Metronomic ABI-007 therapy: antiangiogenic and antitumor activity of a nanoparticle albumin-bound paclitaxel Cancer Research ·Sylvia S. W. Ng, Alex Sparreboom, Yuval Shaked, Christina Lee, Shan Man, Neil Desai, Patrick Soon‐Shiong, William D. Figg, Robert S. Kerbel	2005	2
19	RAPID PURIFICATION OF ISLETS USING MAGNETIC MICROSPHERES COATED WITH ANTI-ACINAR CELL MONOCLONAL ANTIBODIES Transplantation ·Toshio Fujioka, Paul I. Terasaki, R Heintz, N Merideth, Robert Lanza, Tianli Zheng, Patrick Soon‐Shiong	1990	19
20	An in vitro method of assessing the immunoprotective properties of microcapsule membranes using pancreatic and tumor cell targets. PubMed ·Patrick Soon‐Shiong, Marit Sollaart, Iqbal S. Grewal, Robert Lanza, William R. Clark	1990	12

About Patrick Soon‐Shiong

Patrick Soon‐Shiong is a scholar working on Oncology, Immunology, Transplantation, Cancer Research and Gastroenterology, having authored 162 papers that have together received 7.9k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (35 papers), Immune Cell Function and Interaction (26 papers), CAR-T cell therapy research (25 papers), Pancreatic function and diabetes (22 papers), Immunotherapy and Immune Responses (17 papers), Cancer Treatment and Pharmacology (14 papers), Diabetes and associated disorders (13 papers) and Cancer Genomics and Diagnostics (13 papers). The work is most often cited by research in Biomaterials (1.5k citations), Oncology (2.8k citations), Molecular Medicine (316 citations), Cancer Research (957 citations) and Pharmaceutical Science (376 citations). Patrick Soon‐Shiong has collaborated with scholars based in United States, Italy and Canada. Frequent co-authors include Neil Desai, Michael Hawkins, Vuong Trieu, Gudmund Skjåk‐Bræk, Terje Espevik, Olav Smidsrød, Zhiwen Yao, Per Bruheim, R Heintz and Shahrooz Rabizadeh. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, Journal for ImmunoTherapy of Cancer, Scientific Reports and Oncotarget.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact